Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP280064.RA9jfGm16-qV6R6mnxwR4eomWlmJlo8X43xAx4CgQBZbI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP280064.RA9jfGm16-qV6R6mnxwR4eomWlmJlo8X43xAx4CgQBZbI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP280064.RA9jfGm16-qV6R6mnxwR4eomWlmJlo8X43xAx4CgQBZbI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP280064.RA9jfGm16-qV6R6mnxwR4eomWlmJlo8X43xAx4CgQBZbI130_provenance.
- NP280064.RA9jfGm16-qV6R6mnxwR4eomWlmJlo8X43xAx4CgQBZbI130_assertion description "[In this study we examined the effects of VEGF GT on patients having received VEGF-A gene transfer for the treatment of symptomatic (that is, claudication or critical lower limb ischemia) peripheral arterial occlusive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP280064.RA9jfGm16-qV6R6mnxwR4eomWlmJlo8X43xAx4CgQBZbI130_provenance.
- NP280064.RA9jfGm16-qV6R6mnxwR4eomWlmJlo8X43xAx4CgQBZbI130_assertion evidence source_evidence_literature NP280064.RA9jfGm16-qV6R6mnxwR4eomWlmJlo8X43xAx4CgQBZbI130_provenance.
- NP280064.RA9jfGm16-qV6R6mnxwR4eomWlmJlo8X43xAx4CgQBZbI130_assertion SIO_000772 21776026 NP280064.RA9jfGm16-qV6R6mnxwR4eomWlmJlo8X43xAx4CgQBZbI130_provenance.
- NP280064.RA9jfGm16-qV6R6mnxwR4eomWlmJlo8X43xAx4CgQBZbI130_assertion wasDerivedFrom befree-20140225 NP280064.RA9jfGm16-qV6R6mnxwR4eomWlmJlo8X43xAx4CgQBZbI130_provenance.
- NP280064.RA9jfGm16-qV6R6mnxwR4eomWlmJlo8X43xAx4CgQBZbI130_assertion wasGeneratedBy ECO_0000203 NP280064.RA9jfGm16-qV6R6mnxwR4eomWlmJlo8X43xAx4CgQBZbI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP280064.RA9jfGm16-qV6R6mnxwR4eomWlmJlo8X43xAx4CgQBZbI130_provenance.